Healthcare provider profile · identity verified

Herbert Rosenbaum, MD

Family Medicine · CHULA VISTA, CA · NPI 1922532712

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	649	78
Gabapentin	Gabapentin	284	33
Metformin Hcl	Metformin Hcl	267	30
Amlodipine Besylate	Amlodipine Besylate	264	32
Ezetimibe	Ezetimibe	256	30
Tamsulosin Hcl	Tamsulosin Hcl	249	25
Levothyroxine Sodium	Levothyroxine Sodium	233	23
Losartan Potassium	Losartan Potassium	228	25
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	221	20
Lisinopril	Lisinopril	208	29
Pantoprazole Sodium	Pantoprazole Sodium	179	22
Omeprazole	Omeprazole	175	22
Fluticasone Propionate	Fluticasone Propionate	168	41
Alendronate Sodium	Alendronate Sodium	166	20
Carvedilol	Carvedilol	146	18
Jardiance	Empagliflozin	140	14
Escitalopram Oxalate	Escitalopram Oxalate	137	15
Famotidine	Famotidine	128	16
Clopidogrel	Clopidogrel Bisulfate	110	16
Furosemide	Furosemide	92	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	88	15
Eliquis	Apixaban	87	13
Ketoconazole	Ketoconazole	87	13
Trueplus Pen Needle	Pen Needle, Diabetic	84	15
Trazodone Hcl	Trazodone Hcl	82	16
Metoprolol Succinate	Metoprolol Succinate	77	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	74	suppressed
Mirtazapine	Mirtazapine	74	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	67	suppressed
Icosapent Ethyl	Icosapent Ethyl	63	suppressed
Latanoprost	Latanoprost	59	suppressed
Duloxetine Hcl	Duloxetine Hcl	58	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	55	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	52	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	51	20
Sertraline Hcl	Sertraline Hcl	51	suppressed
Enalapril Maleate	Enalapril Maleate	50	suppressed
Januvia	Sitagliptin Phosphate	48	suppressed
Mirabegron Er	Mirabegron	48	11
Trulicity	Dulaglutide	48	suppressed
Ciclopirox	Ciclopirox	45	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	45	suppressed
Xarelto	Rivaroxaban	43	suppressed
Finasteride	Finasteride	41	suppressed
Memantine Hcl	Memantine Hcl	41	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	38	suppressed
Myrbetriq	Mirabegron	36	suppressed
Hydralazine Hcl	Hydralazine Hcl	34	suppressed
Rybelsus	Semaglutide	31	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Repatha Pushtronex	Evolocumab	29	suppressed
Simvastatin	Simvastatin	29	suppressed
Spironolactone	Spironolactone	28	suppressed
Hydrocortisone	Hydrocortisone	26	suppressed
Spiriva Respimat	Tiotropium Bromide	26	suppressed
Benazepril Hcl	Benazepril Hcl	24	suppressed
Donepezil Hcl	Donepezil Hcl	24	suppressed
Lactulose	Lactulose	23	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Colchicine	Colchicine	22	suppressed
Risperidone	Risperidone	22	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	21	suppressed
Rhopressa	Netarsudil Mesylate	21	suppressed
Praluent Pen	Alirocumab	20	suppressed
Pregabalin	Pregabalin	20	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	20	suppressed
Telmisartan	Telmisartan	20	suppressed
Tradjenta	Linagliptin	20	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	19	suppressed
Lansoprazole	Lansoprazole	19	suppressed
Timolol Maleate	Timolol Maleate	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Trulance	Plecanatide	19	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Allopurinol	Allopurinol	17	suppressed
Ozempic	Semaglutide	17	suppressed
Tiotropium Bromide	Tiotropium Bromide	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	16	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	15	suppressed
Dapagliflozin	Dapagliflozin Propanediol	15	suppressed
Insulin Aspart	Insulin Aspart	15	suppressed
Lumigan	Bimatoprost	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	14	suppressed
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Loperamide	Loperamide Hcl	14	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Varenicline Tartrate	Varenicline Tartrate	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	13	suppressed
Celecoxib	Celecoxib	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Linzess	Linaclotide	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Naproxen	Naproxen	13	suppressed
Nitroglycerin	Nitroglycerin	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Potassium Chloride	Potassium Chloride	13	suppressed
Prolia	Denosumab	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Dexlansoprazole Dr	Dexlansoprazole	12	suppressed
Dutasteride	Dutasteride	12	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Pravastatin Sodium	Pravastatin Sodium	11	suppressed
Qvar Redihaler	Beclomethasone Dipropionate	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error